Literature DB >> 27848136

The effect of IDH1 mutation on the structural connectome in malignant astrocytoma.

Shelli R Kesler1, Kyle Noll2, Daniel P Cahill3, Ganesh Rao4, Jeffrey S Wefel2.   

Abstract

Mutation of the IDH1 gene is associated with differences in malignant astrocytoma growth characteristics that impact phenotypic severity, including cognitive impairment. We previously demonstrated greater cognitive impairment in patients with IDH1 wild type tumor compared to those with IDH1 mutant, and therefore we hypothesized that brain network organization would be lower in patients with wild type tumors. Volumetric, T1-weighted MRI scans were obtained retrospectively from 35 patients with IDH1 mutant and 32 patients with wild type malignant astrocytoma (mean age = 45 ± 14 years) and used to extract individual level, gray matter connectomes. Graph theoretical analysis was then applied to measure efficiency and other connectome properties for each patient. Cognitive performance was categorized as impaired or not and random forest classification was used to explore factors associated with cognitive impairment. Patients with wild type tumor demonstrated significantly lower network efficiency in several medial frontal, posterior parietal and subcortical regions (p < 0.05, corrected for multiple comparisons). Patients with wild type tumor also demonstrated significantly higher incidence of cognitive impairment (p = 0.03). Random forest analysis indicated that network efficiency was inversely, though nonlinearly associated with cognitive impairment in both groups (p < 0.0001). Cognitive reserve appeared to mediate this relationship in patients with mutant tumor suggesting greater neuroplasticity and/or benefit from neuroprotective factors. Tumor volume was the greatest contributor to cognitive impairment in patients with wild type tumor, supporting our hypothesis that greater lesion momentum between grades may cause more disconnection of core neurocircuitry and consequently lower efficiency of information processing.

Entities:  

Keywords:  Astrocytoma; Cognition; Connectome; IDH1; MRI

Mesh:

Substances:

Year:  2016        PMID: 27848136      PMCID: PMC5377918          DOI: 10.1007/s11060-016-2328-1

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  60 in total

1.  Structural covariance in the human cortex.

Authors:  Andrea Mechelli; Karl J Friston; Richard S Frackowiak; Cathy J Price
Journal:  J Neurosci       Date:  2005-09-07       Impact factor: 6.167

2.  The smarter, the stronger: intelligence level correlates with brain resilience to systematic insults.

Authors:  Emiliano Santarnecchi; Simone Rossi; Alessandro Rossi
Journal:  Cortex       Date:  2014-12-02       Impact factor: 4.027

Review 3.  Default mode network as a potential biomarker of chemotherapy-related brain injury.

Authors:  Shelli R Kesler
Journal:  Neurobiol Aging       Date:  2014-05-15       Impact factor: 4.673

4.  Evidence for potentials and limitations of brain plasticity using an atlas of functional resectability of WHO grade II gliomas: towards a "minimal common brain".

Authors:  Tamara Ius; Elsa Angelini; Michel Thiebaut de Schotten; Emmanuel Mandonnet; Hugues Duffau
Journal:  Neuroimage       Date:  2011-03-21       Impact factor: 6.556

5.  How does multiple testing correction work?

Authors:  William S Noble
Journal:  Nat Biotechnol       Date:  2009-12       Impact factor: 54.908

Review 6.  Isocitrate dehydrogenase 1: what it means to the neurosurgeon: a review.

Authors:  Tiffany R Hodges; Bryan D Choi; Darell D Bigner; Hai Yan; John H Sampson
Journal:  J Neurosurg       Date:  2013-04-12       Impact factor: 5.115

Review 7.  Diffuse low-grade gliomas and neuroplasticity.

Authors:  H Duffau
Journal:  Diagn Interv Imaging       Date:  2014-09-16       Impact factor: 4.026

8.  Invasion and proliferation kinetics in enhancing gliomas predict IDH1 mutation status.

Authors:  Anne L Baldock; Kevin Yagle; Donald E Born; Sunyoung Ahn; Andrew D Trister; Maxwell Neal; Sandra K Johnston; Carly A Bridge; David Basanta; Jacob Scott; Hani Malone; Adam M Sonabend; Peter Canoll; Maciej M Mrugala; Jason K Rockhill; Russell C Rockne; Kristin R Swanson
Journal:  Neuro Oncol       Date:  2014-06       Impact factor: 12.300

9.  Longitudinal assessment of cognitive changes associated with adjuvant treatment for breast cancer: impact of age and cognitive reserve.

Authors:  Tim A Ahles; Andrew J Saykin; Brenna C McDonald; Yuelin Li; Charlotte T Furstenberg; Brett S Hanscom; Tamsin J Mulrooney; Gary N Schwartz; Peter A Kaufman
Journal:  J Clin Oncol       Date:  2010-09-13       Impact factor: 44.544

10.  The hubs of the human connectome are generally implicated in the anatomy of brain disorders.

Authors:  Nicolas A Crossley; Andrea Mechelli; Jessica Scott; Francesco Carletti; Peter T Fox; Philip McGuire; Edward T Bullmore
Journal:  Brain       Date:  2014-06-19       Impact factor: 13.501

View more
  25 in total

1.  Reply to Freyschlag et al.

Authors:  Jeffrey S Wefel; Kyle R Noll; Ganesh Rao; Daniel P Cahill
Journal:  Neuro Oncol       Date:  2017-04-01       Impact factor: 12.300

2.  Resting-state fMRI detects alterations in whole brain connectivity related to tumor biology in glioma patients.

Authors:  Veit M Stoecklein; Sophia Stoecklein; Franziska Galiè; Jianxun Ren; Michael Schmutzer; Marcus Unterrainer; Nathalie L Albert; Friedrich-W Kreth; Niklas Thon; Thomas Liebig; Birgit Ertl-Wagner; Joerg-C Tonn; Hesheng Liu
Journal:  Neuro Oncol       Date:  2020-09-29       Impact factor: 12.300

3.  Association between tumor location and neurocognitive functioning using tumor localization maps.

Authors:  Esther J J Habets; Eef J Hendriks; Martin J B Taphoorn; Linda Douw; Aeilko H Zwinderman; W Peter Vandertop; Frederik Barkhof; Philip C De Witt Hamer; Martin Klein
Journal:  J Neurooncol       Date:  2019-08-13       Impact factor: 4.130

4.  Identifying cytokine predictors of cognitive functioning in breast cancer survivors up to 10 years post chemotherapy using machine learning.

Authors:  Ashley M Henneghan; Oxana Palesh; Michelle Harrison; Shelli R Kesler
Journal:  J Neuroimmunol       Date:  2018-04-19       Impact factor: 3.478

5.  Functional connectome biotypes of chemotherapy-related cognitive impairment.

Authors:  Shelli R Kesler; Melissa L Petersen; Vikram Rao; Rebecca A Harrison; Oxana Palesh
Journal:  J Cancer Surviv       Date:  2020-03-10       Impact factor: 4.442

6.  Brain Network Connectivity and Executive Function in Long-Term Survivors of Childhood Acute Lymphoblastic Leukemia.

Authors:  Shelli R Kesler; Robert Ogg; Wilburn E Reddick; Nicholas Phillips; Matthew Scoggins; John O Glass; Yin Ting Cheung; Ching-Hon Pui; Leslie L Robison; Melissa M Hudson; Kevin R Krull
Journal:  Brain Connect       Date:  2018-08

7.  Neuropsychological Practice in the Oncology Setting.

Authors:  Kyle R Noll; Mariana E Bradshaw; Jennie Rexer; Jeffrey S Wefel
Journal:  Arch Clin Neuropsychol       Date:  2018-05-01       Impact factor: 2.813

Review 8.  Cognitive impact of lower-grade gliomas and strategies for rehabilitation.

Authors:  Christina Weyer-Jamora; Melissa S Brie; Tracy L Luks; Ellen M Smith; Steve E Braunstein; Javier E Villanueva-Meyer; Paige M Bracci; Susan Chang; Shawn L Hervey-Jumper; Jennie W Taylor
Journal:  Neurooncol Pract       Date:  2020-11-04

9.  New-Onset Postoperative Seizures in Patients With Diffuse Gliomas: A Risk Assessment Analysis.

Authors:  Lianwang Li; Guanzhang Li; Shengyu Fang; Kenan Zhang; Ruoyu Huang; Yinyan Wang; Chuanbao Zhang; Yiming Li; Wei Zhang; Zhong Zhang; Qiang Jin; Dabiao Zhou; Xing Fan; Tao Jiang
Journal:  Front Neurol       Date:  2021-06-18       Impact factor: 4.003

10.  Influence of Epilepsy on the Quality of Life of Patients with Brain Tumors.

Authors:  Stanisław Krajewski; Magdalena Wójcik; Marek Harat; Jacek Furtak
Journal:  Int J Environ Res Public Health       Date:  2021-06-12       Impact factor: 3.390

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.